SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-21-024074
Filing Date
2021-02-16
Accepted
2021-02-16 16:22:25
Documents
1
Group Members
RIDGEBACK CAPITAL INVESTMENTS LLCRIDGEBACK CAPITAL MANAGEMENT LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm215977d6_sc13ga.htm SC 13G/A 91912
  Complete submission text file 0001104659-21-024074.txt   93570
Mailing Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080
Business Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Subject) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90656 | Film No.: 21638926
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 30 STAR ISLAND DRIVE MIAMI BEACH FL 33139
Business Address 30 STAR ISLAND DRIVE MIAMI BEACH FL 33139 212-808-7729
Ridgeback Capital Investments L.P. (Filed by) CIK: 0001423994 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A